Tetrahedron Letters p. 2087 - 2088 (1998)
Update date:2022-08-02
Topics:
Czollner, Laszlo
Frantsits, Werner
Kueenburg, Bernhard
Hedenig, Ursula
Froehlich, Johannes
Jordis, Ulrich
A concise, scalable synthesis of (-)-galanthamine, a drug being used for the treatment of Alzheimer's disease, is described. The yield of the critical phenolic coupling step was optimized to 45-50%. For the reduction of the aryl bromide, air-activated LiAlH4 was used and racemic narwedine was converted to (-)-narwedine by a second order asymmetric transformation.
View MoreShanghai Yurui Biotechnology(Anyang) Pharmaceutical Co., Ltd
Contact:+86-0372-3662335 +86-0372-3661988
Address:hanling industrial park anyang
Huaian Double Win Chemicals Co.,Ltd.
Contact:+86-13511538872
Address:Blk 43,Greenland Century Town,Huaian District, Huaian City,Jiangsu Province,China
SEA BRGIHT INDUSTRY CO.,LIMITED
Contact:0086 755 8622 3990
Address:Rm 17B3,GuangCaiXinTianDi Bldg,GuiMiao Rd,NanShan District,Shenzhen,China
Shanghai Micro-mega Industry Co., Ltd.
Contact:0086-21-34628682;57153848
Address:Rm413,No.413,West Meilong Road, Minhang District,Shanghai P R China
website:http://www.sagechem.com
Contact:+86-571-86818502
Address:Room C1301, New Youth Plaza, 8 Jia Shan Road, Hangzhou, China
Doi:10.1021/ja01532a044
(1959)Doi:10.1039/c3ra47724j
(2014)Doi:10.1016/0022-5088(85)90220-6
(1985)Doi:10.1021/ja01274a008
(1938)Doi:10.1248/cpb.38.2146
(1990)Doi:10.1021/ja00310a065
(1985)
